"10.1371_journal.pone.0122653","plos one","2015-04-16T00:00:00Z","Eva-Maria Zitzmann-Roth; Frank von Sonnenburg; Stephan de la Motte; Nathaly Arndtz-Wiedemann; Alfred von Krempelhuber; Nadine Uebler; Jens Vollmar; Garth Virgin; Paul Chaplin","Praxis Zitzmann-Roth, München, Germany; Department of Infectious Diseases and Tropical Medicine, Section of International Medicine and Public Health, Ludwig-Maximilians-Universität, Munich, Germany; Harrison Clinical Research GmbH, Munich, Germany; Bavarian Nordic GmbH, Martinsried, Germany","Conceived and designed the experiments: SM NA AK NU JV PC. Performed the experiments: FS SM. Analyzed the data: EZ FS SM NA AK NU JV GV PC. Contributed reagents/materials/analysis tools: FS SM. Wrote the paper: EZ FS SM NA AK NU JV GV PC.","SM received honoraria as clinical investigator in this trial. NA and PC are employed for and hold stocks/warrants in Bavarian Nordic. AK, NU, JV and GV were employed by Bavarian Nordic at the time of conduct of the trial. EZ is working as cardiologist in her own private practice, called in German Praxis Zitzmann-Roth. This is no employment, but a private physician practice. SM was employed by Harrison Clinical Research GmbH at the time of this trial. He is still employed with this company, that was in the meantime renamed to SyteractHCR. Harrison Clinical Research GmbH was contracted by Bavarian Nordic as a clinical service provider for this trial. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","04","Eva-Maria Zitzmann-Roth","EMZR",9,TRUE,6,2,9,9,TRUE,TRUE,FALSE,0,NA,FALSE
